Fresh frozen plasma-first approach is independently associated with improved survival in severely injured patients undergoing massive transfusion
Listen to this summary
The authors aimed to determine whether a fresh frozen plasma (FFP)-first approach improves survival in severely injured patients undergoing massive transfusion compared to a packed red blood cell (PRBC)-first approach. Their analysis of over 50,000 patients revealed that the FFP-first strategy was associated with lower six-hour, 24-hour, and in-hospital mortality rates, suggesting a potential benefit of prioritizing FFP in trauma care. They conclude that while the survival advantage is modest, further prospective or randomized trials are needed to confirm these findings.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The journal of trauma and acute care surgery
View all →Jun 10, 2026 · The journal of trauma and acute care surgery
Blunt cerebrovascular injury after ground-level falls: Yield of CT angiography and relevance of the expanded Denver criteria
Jun 8, 2026 · The journal of trauma and acute care surgery
Reconciling the academic mission with workforce reality in acute care surgery
Jun 3, 2026 · The journal of trauma and acute care surgery
Genitourinary trauma: What you need to know
More in Surgery
View all →Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · Annals of surgical oncology
Real-World Analysis of Neoadjuvant Immunochemotherapy Followed by Surgery in Esophageal Cancer with Baseline Supraclavicular Lymph Node Involvement
Sep 23, 2026 · Journal of the American College of Surgeons
Increased Medical Debt in Collections 1 Year After Emergency General Surgery Admission
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


